Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells
In: Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide, Jg. 28 (2007), Heft 9, S. 1883-1890
academicJournal
- print, 48 ref
Zugriff:
The effects of vasoactive intestinal peptide-camptothecin (VIP-CPT) conjugates were investigated on breast cancer cells and cells transfected with VIP receptors (R). (Ala2,8,9,19,24,25,27, Nle17, Lys28)VIP, (A-NL-K)VIP, was synthesized and Lys28 was coupled to a linker, N-methyl-amino-ethyl-glycine, L2, which formed a carbamate bond with CPT. The resulting (A-NL-K)VIP-L2-CPT was cytotoxic for MCF7 breast cancer cells, which have VPAC1-R, with IC50 values of 380 and 90 nM using the MTT and clonogenic assays, respectively. (A-NL-K)VIP, (A-NL-K)VIP-L2 and (A-NL-K)VIP-L2-CPT inhibited specific binding of125I-VIP to 3T3 cells transfected with VPAC1-R with IC50 values of 1.9, 56 and 126 nM, respectively. In contrast, (A-NL-K)VIP, (A-NL-K)VIP-L2 and (A-NL-K)VIP-L2-CPT inhibited specific binding of125I-Ro25-1553 to 3T3 cells transfected with VPAC2-R with IC50 values of 3.9, 3162 and 2690 nM, respectively. (A-NL-K)VIP, (A-NL-K)VIP-L2 and (A-NL-K)VIP-L2-CPT caused increased cAMP after addition to MCF7 cells. 125I-(A-NL-K)VIP-L2-CPT was internalized by MCF7 cells at 37 °C but not 4 °C. These results indicate that (A-NL-K)VIP-L2-CPT is a VPAC1-R agonist which is cytotoxic for breast cancer cells.
Titel: |
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells
|
---|---|
Autor/in / Beteiligte Person: | MOODY, Terry W ; MANTEY, Samuel A ; FUSELIER, Joseph A ; COY, David H ; JENSEN, Robert T |
Link: | |
Zeitschrift: | Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide, Jg. 28 (2007), Heft 9, S. 1883-1890 |
Veröffentlichung: | New York, NY: Elsevier Science, 2007 |
Medientyp: | academicJournal |
Umfang: | print, 48 ref |
ISSN: | 0196-9781 (print) |
Schlagwort: |
|
Sonstiges: |
|